With the influx of “new drug applications” taking up a larger percentage of labor hours, the FDA had to turn to some other alternatives for help. The agency already has a program in place from the 1990s, called the Prescription Drug User Fee Act (PDUFA), which outlines the guidelines and metrics for the FDA to review a drug. Drug companies pay significant fees to the agency when submitting their applications, which now totals more than $2.8 trillion for trials involving clinical data.
20+ curated newsletters
，更多细节参见一键获取谷歌浏览器下载
Taken together, the two papers trace the outlines of a labor market transformation that is squeezing workers from both ends: AI encroaching from the top, automation moving in from the bottom.
妈妈气愤的质疑学而思学习机和喜马拉雅软件平台监管审核不严。